Invention Grant
- Patent Title: Chiral diaryl macrocycles as modulators of protein kinases
-
Application No.: US16425407Application Date: 2019-05-29
-
Publication No.: US11008337B2Publication Date: 2021-05-18
- Inventor: Jingrong J. Cui , Yishan Li , Evan W. Rogers , Dayong Zhai , Wei Deng , Jane Ung
- Applicant: Turning Point Therapeutics, Inc.
- Applicant Address: US CA San Diego
- Assignee: Turning Point Therapeutics, Inc.
- Current Assignee: Turning Point Therapeutics, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
- Main IPC: A61K31/407
- IPC: A61K31/407 ; A61K31/4353 ; C07D209/56 ; C07D221/22 ; C07D498/22 ; C07D498/14
Abstract:
The present disclosure relates to certain chiral diaryl macrocyclic derivatives, of the formula I: pharmaceutical compositions containing them, and methods of using them to treat cancer, pain, neurological diseases, autoimmune diseases, and inflammation.
Public/Granted literature
- US20190284209A1 CHIRAL DIARYL MACROCYCLES AS MODULATORS OF PROTEIN KINASES Public/Granted day:2019-09-19
Information query
IPC分类:
